Account Login
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biohaven Pharmaceutical Holding Company Ltd (NY: BHVN )

73.19 USD -1.21 (-1.63%)
Streaming Delayed Price Updated: 2:59 PM EDT, Apr 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 310,710
Open 73.32
Bid (Size) 73.04 (1)
Ask (Size) 73.26 (1)
Prev. Close 74.40
Today's Range 72.06 - 74.14
52wk Range 37.92 - 100.77
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Biohaven Highlights Neuroscience Advancements with 22 Presentations at the 2021 American Academy of Neurology (AAN) Virtual Annual Meeting
- Pivotal trial of rimegepant for the preventive treatment of migraine spotlights reduction of 4.3 monthly migraine days during weeks 9-12 and rapid onset of preventive effects observed within the... 
From PR Newswire
Biohaven Announces Preliminary 1Q2021 Net Product Revenue For NURTEC ODT
- NURTEC® ODT achieved preliminary net product revenue of approximately $43.8 million for the first quarter of 2021 
From PR Newswire

Performance

YTD
-10.65%
-10.65%
1 Month
+3.86%
+3.86%
3 Month
-5.96%
-5.96%
6 Month
-5.55%
-5.55%
1 Year
+75.10%
+75.10%

More News

Read More
Rick Ware Racing, Biohaven's Nurtec ODT and Nine Line Apparel Honor Fallen Service Members
From PR Newswire
Biohaven Enrolls First Patient in Phase 2/3 Trial of Oral Zavegepant, Prompting $100 Million Milestone Funding Payment from Royalty Pharma
From PR Newswire
Biohaven Announces Pricing Of $200 Million Public Offering Of Common Shares
From PR Newswire
December 17th Options Now Available For Biohaven Pharmaceutical Holding (BHVN)
Tags Stocks
From Market News Video
Biohaven Announces Proposed Public Offering Of Common Shares
From PR Newswire
Biohaven Crushes Forecasts; What's Next For Its Blockbuster Hopeful?
From Investor's Business Daily
Biohaven Secures $100M Milestone Funding After Enrolling First Patient In Migraine Study With Oral Zavegepant
Tags FDA Financing Market News
From Benzinga
Dow Moves Lower as S&P 500 Eyes New Peak
Tags Market News Stocks / Equities
From Blogs - TalkMarkets
Biohaven Crushes Forecasts; What's Next For Its Blockbuster Hopeful?
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.